TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
WELL

Welltower Inc

Real Estate · REIT - Healthcare Facilities

231.40$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios WELL
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
11.3 13.3 10.8 5.7 6.9 12.5 14.9 19.2 23.3 21.9 26.0 25.7 14.0 26.3 47.5 43.7 46.6 103.0 45.5 26.9 22.4 45.0 32.4 26.8 27.5 109.0 216.1 137.6 80.6 134.6
6.3 8.4 6.9 3.3 4.0 7.0 7.7 9.4 8.8 6.6 9.3 8.3 7.6 9.7 10.7 7.3 7.7 5.2 7.0 6.2 5.7 5.5 5.6 6.5 5.9 7.8 5.3 7.2 9.8 11.8
1.1 1.3 1.1 0.6 0.7 1.0 1.1 1.4 1.5 1.3 1.3 1.5 1.2 1.3 1.3 1.3 1.3 1.3 1.7 1.6 1.6 1.6 1.8 2.1 1.6 2.1 1.4 1.8 2.4 3.0
8.0 9.5 8.6 4.7 8.7 11.4 13.7 14.3 14.5 11.6 16.4 14.3 12.9 14.2 18.3 13.0 11.9 8.8 13.3 9.5 8.5 8.1 8.4 9.3 8.6 10.7 9.9 9.6 11.3 13.2
9.1 8.1 7.0 3.6 6.2 11.2 13.6 14.5 11.4 12.1 16.9 15.6 15.1 17.6 27.0 20.2 19.5 17.6 25.9 18.5 16.8 20.3 20.4 22.3 25.9 29.5 28.1 25.9 31.9 60.7
– – – – 12.9 – – – – – – – – – – – 17.1 15.2 20.6 17.4 15.0 16.6 16.5 21.7 20.0 29.2 23.5 30.2 34.9 44.3
-8.6% -13.0% -28.9% -27.8% 7.8% -7.7% -30.1% -17.7% -70.8% -23.0% -8.0% -10.3% -18.5% -5.1% -28.4% -45.6% 5.8% 6.6% 4.9% 5.7% 6.7% 6.0% 6.1% 4.6% 5.0% 3.4% 4.3% 3.3% 2.9% 2.3%
Margins
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.6% 92.2% 91.9% 91.9% 86.4% 71.2% 68.4% 58.0% 57.9% 57.8% 55.9% 51.5% 47.9% 47.3% 43.4% 41.1% 38.4% 39.1% 38.5% 39.2%
83.3% 108.2% 111.2% 114.5% 119.1% 70.2% 67.0% 65.4% 58.2% 64.1% 61.9% 54.6% 55.5% 51.1% 42.7% 35.4% 33.4% 24.1% 28.3% 32.4% 30.8% 25.8% 24.9% 24.3% 15.9% 16.2% 12.9% 14.5% 14.6% 3.3%
56.4% 63.4% 63.6% 58.4% 58.1% 56.2% 51.9% 48.6% 37.8% 29.9% 35.6% 32.2% 53.8% 36.9% 22.5% 16.7% 16.5% 5.0% 15.4% 23.0% 25.4% 12.2% 17.2% 24.2% 21.3% 7.1% 2.4% 5.2% 12.1% 8.8%
-54.9% -108.9% -198.2% -92.2% 31.0% -54.2% -233.3% -165.1% -623.0% -151.0% -73.8% -85.5% -140.0% -49.5% -302.8% -332.6% 44.9% 34.1% 33.9% 35.5% 37.9% 33.0% 33.7% 29.8% 29.4% 26.7% 22.5% 23.9% 28.0% 26.7%
Returns
9.4% 9.9% 9.8% 10.7% 9.7% 8.0% 7.5% 7.2% 6.4% 5.9% 5.2% 5.8% 8.8% 5.1% 2.8% 3.1% 2.9% 1.3% 3.8% 6.1% 7.3% 3.6% 5.5% 7.9% 5.7% 1.9% 0.7% 1.3% 3.0% 2.2%
5.9% 6.3% 5.8% 5.9% 5.9% 4.8% 4.2% 3.8% 3.3% 2.8% 2.4% 2.7% 4.6% 3.0% 1.4% 1.5% 1.5% 0.6% 2.0% 3.0% 3.7% 1.9% 2.7% 3.7% 3.0% 1.0% 0.4% 0.8% 1.9% 1.4%
Balance Sheet & Debt
92 77 170 175 557 469 776 843 1,281 1,422 2,050 2,604 2,801 2,366 4,338 7,483 7,498 10,493 21,131 12,607 11,939 11,488 13,082 14,630 12,705 13,862 26,770 15,518 11,994 14,164
1.9 0.9 1.4 1.0 3.4 4.3 5.9 5.0 4.4 5.3 7.3 6.6 6.2 5.6 11.2 8.9 6.8 7.3 12.3 6.4 5.6 6.7 6.8 6.8 8.3 8.1 13.1 6.5 4.3 6.1
62.6% 64.0% 59.0% 55.6% 60.4% 59.7% 56.3% 52.7% 52.4% 48.1% 46.3% 46.1% 51.9% 59.6% 48.7% 47.7% 52.7% 49.4% 54.2% 50.3% 51.3% 51.6% 48.2% 46.6% 53.0% 50.5% 56.5% 57.7% 62.6% 62.6%
0.3 0.2 0.3 0.3 0.8 0.6 0.9 0.8 1.0 1.0 1.1 1.1 0.9 0.6 1.0 1.1 0.8 0.9 1.6 0.9 0.8 0.8 0.9 1.0 0.8 0.8 1.3 0.7 0.5 0.5
Per Share
2.18 2.12 2.40 2.66 2.38 1.95 1.81 1.87 1.64 1.55 1.66 1.74 3.00 1.69 1.00 1.25 1.32 0.52 1.66 2.53 2.99 1.42 2.15 3.05 2.35 0.79 0.30 0.66 1.56 1.38
3.86 3.34 3.78 4.55 4.09 3.47 3.50 3.85 4.34 5.17 4.65 5.41 5.58 4.57 4.46 7.46 7.97 10.32 10.84 10.99 11.80 11.65 12.45 12.63 10.99 11.03 12.42 12.49 12.90 15.70
23.10 21.42 24.43 24.88 24.39 24.43 24.05 26.01 25.64 26.25 31.89 30.28 34.05 33.13 35.90 40.85 45.56 40.95 44.06 41.76 41.10 39.09 38.99 38.48 41.27 41.32 45.99 48.98 52.49 62.00
-2.12 -3.64 -7.49 -4.20 1.27 -1.88 -8.16 -6.35 -27.04 -7.81 -3.43 -4.63 -7.81 -2.26 -13.50 -24.83 3.58 3.52 3.68 3.91 4.47 3.85 4.20 3.77 3.23 2.94 2.79 2.99 3.61 4.19

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?